Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in northeast Iran

AIDS Research and Human Retroviruses

Volumn 24, Issue 9, 2008, Pages 1155-1158

  Ayatollahi, H ^a   Rafatpanah, H ^b   Khayyami, M E ^a   Sayyadpour, D ^a   Ravarian, M ^a   Sadeghian, M H ^a   Izadi, N ^a   Khoob, M Khabbaz ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RH; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS INFECTION; WESTERN BLOTTING;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BLOOD DONORS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DELTARETROVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY, NATURAL; IRAN; MALE; MIDDLE AGED; RH-HR BLOOD-GROUP SYSTEM; STATISTICS AS TOPIC;

EID: 51849084887     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0002     Document Type: Article

References (26)

1. Gessain A, Barin F, Vernant JC, et al.: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2(8452):407-410.
2. Hinuma Y, Nagata K, Hanaoka M, et al.: Adult T-cell leukaemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-6480.
3. Manns A, Hisada M, and La Grenade L: Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-1958.
4. Safai B, Huang JL, Boeri E, et al.: Prevalence of HTLV type I infection in Iran: A serological and genetic study. AIDS Res Hum Retroviruses 1996;12:1185-1190.
5. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, and Abbaszadegan M: Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 2003;41:2593-2595.
6. Kira J, Nakamura M, Sawada T, et al.: Antibody titers to HTLV-I-p40 Tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with increased HTLV-I proviral DNA load. J Neurol Sci 1992;107:98-104.
7. Kira J, Koyanagi Y, Yamada T, et al.: Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study. Ann Neurol 1991;29:194-201.
8. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, and Jacobson S: High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 1993;177:1567-1573.
9. Hill AV: The immunogenetics of human infectious diseases. Annu Rev Immunol 1998;16:593-617.
10. Tsukasaki K, Miller CW, Kubota T, et al.: Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukaemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001;61:3770-3774.
11. Vine AM, Witkover AD, Lloyd AL, et al.: Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2002;186:932-939.
12. Jeffery KJ, Usuku K, Hall SE, et al.: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999;96:3848-3853.
13. Jeffery KJ, Siddiqui AA, Bunce M, et al.: The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000;165:7278-7284.
14. Rafatpanah H, Pravica V, Faridhosseini R, et al.: Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection. Iran J Immunol 2007;4:94-100.
15. Maubert B, Fievet N, Tami G, Boudin C, and Deloron P: Plasmodium falciparum-isolates from Cameroonian pregnant women do not rosette. Parasite 1998;5:281-283.
16. Fischer PR and Boone P: Short report: Severe malaria associated with blood group. Am J Trop Med Hyg 1998;58:122-123.
17. Barragan A, Klremssner PG, Wahlgre M, and Carlson J: Blood group A antigen is a co-receptor in Plasmodium falciparum rosetting. Infect Immun 2000;68:2971-2975.
18. Pathirana SL, Alles HK, Bandara S, et al.: ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Ann Trop Med Parasitol 2005;99:119-124.
19. Cserti CM and Dzik WH: The ABO blood group system and Plasmodium falciparum malaria. Blood 2007;11:2250-2258.
20. Ziegler T, Jacobson N, and Fünfstück R: Correlation between blood group phenotype and virulance properties of Escherichia coli in patients with chronic urinary infection. Int J Antimicrob Agents 2004;24(Suppl. 1):S70-75.
21. Nozoe T, Ezaki T, Baba H, Kakeji Y, and Maehara Y: Correlation of ABO blood group with clinicopathologic characteristics of patients with esophageal squamous cell carcinoma. Dis Esophagus 2004;17:146-149.
22. Manel N, Battini JL, Taylor N, and Sitbon M: HTLV-1 tropism and envelope receptor. Oncogene 2005;5:24:6016-6025.
23. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, and Battini JL: The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003;115:449-459.
24. Takenouchi N, Jones KS, Lisinski I, et al.: GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol 2007;81:1506-1510.
25. Yasunaga JI, Sakai T, Nosaka K, et al.: Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: Its implications in the immunodeficient state. Blood 2001;97:3177-3183.
26. Ukaejiofo EO and Nubila T: Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIV/AIDS-TB co-infected patients in Enugu Urban, Nigeria. West Afr J Med 2006;25:61-64.